Researchers looked at a cancer therapy drug and found biosimilars bring competition to the market, with prices declining by more than half for some versions.
The mentorship effort provides support and access for pursuit of social impact-oriented careers.
TITLE IX: Since becoming an administrator, Theda Douglas has made a difference in the lives of thousands of participants in her programs.
Latinos represent only a small fraction of people enrolled in Alzheimer’s-related clinical trials. USC researcher María Aranda has some ideas on how to fix that.
USC Viterbi researchers seek to upcycle waste materials by harnessing the power of microorganisms.
With a $1 million prize from the Kidney Innovation Accelerator, or KidneyX, USC Stem Cell scientists are on a quest to build a “kidney” that resembles the real thing in function, if not in form.
The $38 million project will feature spectator viewing decks and social spaces, a state-of-the-art press box, concession stands and a capacity of 2,500.
An international leader in Alzheimer’s disease research for over 30 years, Aisen is recognized with the highest academic honor at the Keck School of Medicine of USC.
USC Dornsife’s Sergey Nuzhdin on how the evolution of crops may point toward their sustainable future.
New performances share more of Saks’ memoir, The Center Cannot Hold: My Journey Through Madness, which documents the USC Gould professor’s diagnosis with schizophrenia and her resilience as she learned to cope with the disorder.
